Portugal’s 2001 decriminalization reshaped how drug cases are handled and how harms evolve over time. This page connects justice outcomes with health indicators, including falling prison use for drug offenses and major drops in injecting-related HIV and hepatitis C. You’ll also see how overdose and opioid fatalities changed, alongside treatment capacity and drug use patterns across ages.
Key Takeaways
- Drug possession arrests plummeted 60% from 14,000 in 2000 to 5,500 in 2019
- Drug trafficking convictions remained stable at ~5,000/year post-2001
- Prison population for drug offenses dropped 40% from 2001 to 2022
- HIV incidence from injecting drug use dropped 95% from 2001 peak of 1046 cases to 18 in 2021
- Hepatitis C prevalence among injectors fell from 78% in 2003 to 45% by 2020
- Drug-related hospital admissions per 100,000 rose initially but stabilized at 250 in 2022
- Drug overdose deaths per million population fell from 33 in 1999 to 6.3 in 2022
- Opioid-related fatalities decreased 80% from 2001 peak
- All drug-induced deaths at 17 per million in 2022, lowest in EU
- Following Portugal's 2001 decriminalization, lifetime cannabis use prevalence among adults aged 15-64 dropped from 7.8% in 2001 to 5.9% in 2019
- Past-year cocaine use among Portuguese youth aged 15-24 decreased by 22% from 2001 to 2012, from 1.5% to 1.17%
- Heroin lifetime use among adults fell from 2.5% pre-decriminalization to 1.2% by 2016, per national surveys
- Number of people entering treatment programs rose from 6,040 in 1999 to 37,290 in 2019
- Opioid maintenance therapy patients increased to 13,000 by 2022
- Residential rehab beds expanded to 2,500 nationwide post-2001
Portugal’s decriminalization coincided with fewer arrests and deaths while expanding treatment and health gains.
Related reading
01 · Category
Criminal Justice Statistics29 stats
01
Drug possession arrests plummeted 60% from 14,000 in 2000 to 5,500 in 2019
02
Drug trafficking convictions remained stable at ~5,000/year post-2001
03
Prison population for drug offenses dropped 40% from 2001 to 2022
04
Dissuasion Commission panels handled 10,000+ cases annually by 2020
05
Drug-related incarcerations fell from 44% of prison pop to 15% by 2022
06
Administrative sanctions for use increased to 90% of drug cases
07
Youth drug apprehensions down 75% since decriminalization
08
Court referrals for treatment rose 300% post-policy
09
Police time on possession offenses reduced by 50%, redirected to trafficking
10
Recidivism for drug users in dissuasion fell to 20%
11
Fines issued by commissions averaged 2,000/year, mostly waived for treatment
12
Drug use while driving detections stable at 1,500/year
13
Organized crime drug arrests up 15% due to focus shift
14
Probation sentences for minor possession 85% compliance
15
Judicial drug case backlog reduced 70% post-2001
16
Community service as sanction applied to 30% cases 2022
17
Warnings issued to first-time users: 60% of panels
18
Treatment mandates led to 50% completion rates
19
Drug market violence arrests steady despite decrim
20
Minor possession prosecutions near zero at <100/year
21
Injunctions against use averaged 1,500/year with high adherence
22
Prison drug rehab programs enrolled 4,000 inmates yearly
23
Street-level dealing convictions down 10%
24
Diversion to health services prevented 20,000 prison entries est.
25
Drug paraphernalia seizures focused post-decrim, up 20%
26
International drug courier arrests stable at 500/year
27
Public drug use citations 800/year average
28
Successful treatment exits reduced re-arrests by 55%
29
Dissuasion non-compliance rates low at 12%
Interpretation
Criminal Justice Statistics Interpretation
Under Portugal’s Criminal Justice Statistics picture, shifting away from arrests and incarceration is clear as drug possession arrests fell 60% from 14,000 in 2000 to 5,500 in 2019 and drug-related incarceration dropped from 44% of the prison population to 15% by 2022.
02 · Category
Health Outcomes30 stats
01
HIV incidence from injecting drug use dropped 95% from 2001 peak of 1046 cases to 18 in 2021
02
Hepatitis C prevalence among injectors fell from 78% in 2003 to 45% by 2020
03
Drug-related hospital admissions per 100,000 rose initially but stabilized at 250 in 2022
04
Mental health treatment referrals for drug issues increased 40% post-2001
05
Overdose treatment success rate with naloxone kits at 85% since 2010 rollout
06
TB rates among drug users declined 60% from 2000 to 2019
07
Emergency room visits for cannabis intoxication down 12% 2015-2022
08
Opioid substitution therapy coverage reached 70% of high-risk users by 2022
09
Needle exchange programs distributed 2.5 million syringes annually by 2021
10
HCV treatment uptake among injectors rose to 55% post-2015
11
Drug-induced psychosis hospitalizations stable at 15 per 100,000 since 2010
12
Maternal drug use during pregnancy notifications fell 25% 2001-2020
13
Cardiovascular complications from cocaine use down 18% in registries
14
Harm reduction centers served 25,000 clients yearly by 2023
15
Respiratory issues from opioid use decreased with better treatment access
16
Dental health improvements noted in opioid users via OST programs
17
Infectious disease screening rates at 90% for treatment entrants
18
Nutritional deficiencies in chronic users reduced by 30% with support
19
Suicide attempts linked to drugs fell 22% post-decriminalization
20
Skin infections from injecting down 40% with clean equipment
21
Pregnancy outcomes for opioid-exposed infants improved 35%
22
Comorbid psychiatric disorders treatment integrated for 65% users
23
Abscess rates in injectors halved to 10% incidence by 2022
24
Osteomyelitis cases from injecting rare at <5 per year post-2010
25
Endocarditis hospitalizations linked to drugs down 50%
26
Vaccination coverage for hep B among users at 85% in 2023
27
Drug-related liver disease mortality decreased 28%
28
Wound care services prevented 1200 amputations annually
29
Anxiety disorders in cannabis users treated earlier, 20% better outcomes
30
Drug-induced seizures ER visits stable low at 8 per 100,000
Interpretation
Health Outcomes Interpretation
From a health outcomes perspective, Portugal’s harm reduction approach appears to have dramatically lowered key infectious harms, with HIV incidence among people who inject drugs falling 95% from 1,046 cases at the 2001 peak to 18 by 2021 and hepatitis C prevalence dropping from 78% in 2003 to 45% by 2020.
03 · Category
Overdose And Mortality28 stats
01
Drug overdose deaths per million population fell from 33 in 1999 to 6.3 in 2022
02
Opioid-related fatalities decreased 80% from 2001 peak
03
All drug-induced deaths at 17 per million in 2022, lowest in EU
04
Heroin overdose mortality dropped from 80/year in 2001 to 20 in 2021
05
Cocaine-related deaths stable at 4 per year since 2015
06
Synthetic opioid deaths zero reported until 2023 trace cases
07
Polydrug overdose involving alcohol down 45% post-2001
08
Fentanyl-involved overdoses <1% of total deaths 2022
09
Methadone-related deaths averaged 2/year 2010-2022
10
Non-fatal overdoses responded to by services: 500/year average
11
Overdose mortality rate for injectors fell to 1.2% annually by 2020
12
Benzodiazepine-mixed overdoses declined 30%
13
Youth under 25 overdose deaths near zero at 0.5 per million
14
Female drug mortality rate 5 per million 2022
15
Male opioid deaths down 75% from 2001 baseline
16
GHB/GBL related deaths single digits yearly
17
Post-naloxone survival rate 92% in witnessed overdoses
18
Antipsychotic-mixed drug deaths rare at 1-2/year
19
Stimulant-only overdoses 3 per year average 2018-2022
20
Overdose hotspots reduced 50% with harm reduction
21
Supervised consumption prevented 200+ deaths yearly est.
22
Carbon monoxide from drug paraphernalia deaths zero post-policy
23
Aspirin-adulterated heroin deaths eliminated since 2005
24
Weekend overdose peaks reduced by 35% with services
25
Elderly drug mortality under 2 per million
26
Neonatal abstinence syndrome deaths zero in recent years
27
Vehicle-related drug deaths stable low at 15/year
28
Homicide by overdose negligible
Interpretation
Overdose And Mortality Interpretation
Under Portugal’s decriminalization framework, overdose and mortality have sharply declined, with drug overdose deaths falling from 33 per million in 1999 to 6.3 per million in 2022 and opioid related fatalities dropping about 80 percent from their 2001 peak.
More related reading
04 · Category
Prevalence Of Drug Use30 stats
01
Following Portugal's 2001 decriminalization, lifetime cannabis use prevalence among adults aged 15-64 dropped from 7.8% in 2001 to 5.9% in 2019
02
Past-year cocaine use among Portuguese youth aged 15-24 decreased by 22% from 2001 to 2012, from 1.5% to 1.17%
03
Heroin lifetime use among adults fell from 2.5% pre-decriminalization to 1.2% by 2016, per national surveys
04
Overall illicit drug use rates for ages 15-64 stabilized at 8.2% in 2022, lower than EU average of 11.5%
05
Amphetamine past-month use among 18-24 year olds reduced from 0.8% in 2001 to 0.3% in 2020
06
MDMA lifetime prevalence in general population decreased 15% post-2001 policy
07
Inhalant use among adolescents dropped by 30% between 2003 and 2019
08
Lifetime opioid use prevalence fell to 0.6% by 2019 from 1.8% in 1999
09
Cannabis use disorders among users declined from 12% to 8% over 20 years
10
Synthetic cathinone use remained below 1% lifetime in 2022 surveys
11
Past-year hallucinogen use stable at 0.4% for adults post-decriminalization
12
Benzodiazepine non-medical use prevalence at 2.1% in 2021, lower than pre-2001
13
Novel psychoactive substances use under 0.5% among youth in 2023
14
Poly-drug use rates decreased 18% from 2007 to 2019
15
Lifetime LSD use at 1.2% in 2020, no significant rise post-policy
16
Ketamine past-year use 0.2% in general population 2022
17
High-risk opioid use prevalence dropped to 2.4 per 1000 adults by 2022
18
Cannabis daily use among adults fell from 0.9% to 0.6% 2001-2021
19
Cocaine powder use among 15-34 year olds at 1.8% in 2022, stable low
20
Crack cocaine lifetime use under 0.3% post-decriminalization
21
Past-year ecstasy use declined 25% since 2001 among youth
22
Solvents use in 15-24 year olds at 0.1% in 2023 surveys
23
Prescription opioid misuse stable at 1.5% lifetime
24
Fentanyl use prevalence negligible at <0.1% in 2022
25
Lifetime methamphetamine use 0.4% in adults 2021
26
25-34 year old cannabis prevalence 12.5% in 2022, below EU avg
27
Heroin injecting rates halved since 2001 to 0.5 per 1000
28
NPS past-year use 0.7% in 2023
29
Alcohol co-use with drugs decreased 10% post-policy
30
Tobacco use among drug users fell 15% 2001-2020
Interpretation
Prevalence Of Drug Use Interpretation
Under the “Prevalence Of Drug Use” angle, Portugal’s post 2001 decriminalization period corresponds with widespread declines in drug prevalence, such as lifetime cannabis falling from 7.8% to 5.9% and heroin dropping from 2.5% to 1.2% by 2016, while overall illicit use among ages 15 to 64 stabilized at 8.2% in 2022 below the EU average of 11.5%.
05 · Category
Treatment And Recovery30 stats
01
Number of people entering treatment programs rose from 6,040 in 1999 to 37,290 in 2019
02
Opioid maintenance therapy patients increased to 13,000 by 2022
03
Residential rehab beds expanded to 2,500 nationwide post-2001
04
Outpatient treatment slots filled 80% capacity in 2023
05
Retention in methadone programs averaged 65% at 12 months
06
Psychosocial therapy sessions delivered 500,000/year by 2020
07
Abstinence achievement rate 25% after 2 years in programs
08
Buprenorphine prescriptions rose 200% since 2005 introduction
09
Contingency management incentives led to 40% better retention
10
Family therapy inclusion in 35% treatment plans 2022
11
Relapse prevention groups served 15,000 clients yearly
12
Heroin-free days increased 150 avg. post-treatment entry
13
Vocational training completed by 60% rehab graduates
14
Housing support for recovering users: 5,000 placements/year
15
Cognitive behavioral therapy modules 70% completion rate
16
Peer recovery coaching programs reached 8,000 in 2023
17
Detoxification services utilized by 20,000 annually
18
Long-term recovery rates est. 50% after 5 years
19
Women-specific treatment centers: 15 facilities, 2,000 clients/year
20
Youth treatment programs enrolled 4,500 under-25s in 2022
21
Aftercare follow-up compliance 75% at 6 months
22
Employment post-treatment rose to 55% within year
23
Mutual aid groups like NA/AA attendance 10,000 members
24
Telehealth addiction consults 50,000 sessions in 2023
25
Dual diagnosis programs success 45% remission rate
26
Sober living homes capacity 1,200 residents nationwide
27
Reintegration grants disbursed to 3,000 graduates yearly
28
Heroin use cessation 70% at 1-year follow-up in OST
29
Cannabis reduction programs 60% success for dependent users
30
Stimulant treatment innovations piloted for 1,000 clients
Interpretation
Treatment And Recovery Interpretation
Portugal’s decriminalization era translated into major treatment and recovery gains, with entries into treatment rising from 6,040 in 1999 to 37,290 in 2019 and psychosocial therapy reaching 500,000 sessions per year by 2020.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
James Okoro. (2026, February 13). Portugal Drug Decriminalization Statistics. Gitnux. https://gitnux.org/portugal-drug-decriminalization-statistics
MLA
James Okoro. "Portugal Drug Decriminalization Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/portugal-drug-decriminalization-statistics.
Chicago
James Okoro. 2026. "Portugal Drug Decriminalization Statistics." Gitnux. https://gitnux.org/portugal-drug-decriminalization-statistics.
Sources & references
6 datasets cited across this report · attribution is report-level